Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

omnicell inc. - OMCL

OMCL

Close Chg Chg %
35.57 -0.10 -0.28%

Pre-Market

35.47

-0.10 (0.28%)

Volume: 307.11K

Last Updated:

Apr 9, 2026, 4:00 PM EDT

Trade Now

Company Overview: omnicell inc. - OMCL

OMCL Key Data

Open

$35.24

 Day Range

34.48 - 35.73

52 Week Range

22.66 - 55.00

 Market Cap

$1.62B

Shares Outstanding

45.44M

 Public Float

44.09M

Beta

0.86

 Rev. Per Employee

N/A

P/E Ratio

802.93

 EPS

$0.04

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

544.15K

  

OMCL Performance

1 Week
 
 3.87%
 
1 Month
 
 3.11%
 
3 Months
 
 -30.09%
 
1 Year
 
 13.72%
 
5 Years
 
 -73.67%
 

OMCL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 8
Full Ratings ➔

About omnicell inc. - OMCL

Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.

OMCL At a Glance

Omnicell, Inc.
4220 North Freeway
Fort Worth, Texas 76137
Phone 1-877-415-9990 Revenue 1.18B
Industry Information Technology Services Net Income 2.05M
Sector Technology Services 2025 Sales Growth 6.528%
Fiscal Year-end 12 / 2026 Employees 3,580
View SEC Filings

OMCL Valuation

P/E Current 802.935
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 1,022.573
Price to Sales Ratio 1.773
Price to Book Ratio 1.656
Price to Cash Flow Ratio 16.50
Enterprise Value to EBITDA 20.89
Enterprise Value to Sales 1.733
Total Debt to Enterprise Value 0.10

OMCL Efficiency

Revenue/Employee 330,962.291
Income Per Employee 573.184
Receivables Turnover 5.118
Total Asset Turnover 0.579

OMCL Liquidity

Current Ratio 1.404
Quick Ratio 1.192
Cash Ratio 0.527

OMCL Profitability

Gross Margin 42.878
Operating Margin 0.985
Pretax Margin 0.956
Net Margin 0.173
Return on Assets 0.10
Return on Equity 0.166
Return on Total Capital 0.143
Return on Invested Capital 0.143

OMCL Capital Structure

Total Debt to Total Equity 16.589
Total Debt to Total Capital 14.229
Total Debt to Total Assets 10.348
Long-Term Debt to Equity 15.618
Long-Term Debt to Total Capital 13.396
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Omnicell Inc. - OMCL

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.30B 1.15B 1.11B 1.18B
Sales Growth
+14.48% -11.48% -3.04% +6.53%
Cost of Goods Sold (COGS) incl D&A
698.94M 647.18M 636.73M 676.80M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
99.17M 95.56M 89.75M 86.63M
Depreciation
63.97M 63.96M 42.02M 43.24M
Amortization of Intangibles
35.20M 31.60M 47.73M 43.40M
COGS Growth
+21.14% -7.41% -1.61% +6.29%
Gross Income
597.00M 499.93M 475.51M 508.04M
Gross Income Growth
+7.56% -16.26% -4.89% +6.84%
Gross Profit Margin
+46.07% +43.58% +42.75% +42.88%
2022 2023 2024 2025 5-year trend
SG&A Expense
576.52M 519.26M 470.02M 496.38M
Research & Development
101.35M 93.29M 89.99M 87.73M
Other SG&A
475.17M 425.97M 380.02M 408.64M
SGA Growth
+27.32% -9.93% -9.48% +5.61%
Other Operating Expense
- - - -
-
Unusual Expense
22.80M 15.54M (2.36M) 6.50M
EBIT after Unusual Expense
(2.32M) (34.87M) 7.85M 5.16M
Non Operating Income/Expense
4.37M 19.29M 22.26M 10.07M
Non-Operating Interest Income
- - 24.90M 11.90M
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
4.50M 4.53M 4.53M 3.91M
Interest Expense Growth
-79.88% +0.56% -0.09% -13.59%
Gross Interest Expense
4.50M 4.53M 4.53M 3.91M
Interest Capitalized
- - - -
-
Pretax Income
(2.45M) (20.11M) 25.59M 11.32M
Pretax Income Growth
-103.72% -719.73% +227.28% -55.75%
Pretax Margin
-0.19% -1.75% +2.30% +0.96%
Income Tax
(8.10M) 263.00K 13.06M 9.27M
Income Tax - Current - Domestic
26.00M 10.03M 26.77M 8.80M
Income Tax - Current - Foreign
192.00K 840.00K 846.00K 982.00K
Income Tax - Deferred - Domestic
(33.73M) (10.26M) (14.30M) 192.00K
Income Tax - Deferred - Foreign
(561.00K) (341.00K) (252.00K) (700.00K)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
5.65M (20.37M) 12.53M 2.05M
Minority Interest Expense
- - - -
-
Net Income
5.65M (20.37M) 12.53M 2.05M
Net Income Growth
-92.74% -460.68% +161.51% -83.62%
Net Margin Growth
+0.44% -1.78% +1.13% +0.17%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
5.65M (20.37M) 12.53M 2.05M
Preferred Dividends
- - - -
-
Net Income Available to Common
5.65M (20.37M) 12.53M 2.05M
EPS (Basic)
0.1272 -0.4506 0.2721 0.0446
EPS (Basic) Growth
-92.90% -454.25% +160.39% -83.61%
Basic Shares Outstanding
44.40M 45.21M 46.05M 45.97M
EPS (Diluted)
0.1231 -0.4506 0.2709 0.0443
EPS (Diluted) Growth
-92.42% -466.04% +160.12% -83.65%
Diluted Shares Outstanding
45.89M 45.21M 46.26M 46.36M
EBITDA
119.65M 76.23M 95.25M 98.30M
EBITDA Growth
-36.07% -36.29% +24.95% +3.21%
EBITDA Margin
+9.23% +6.65% +8.56% +8.30%

Snapshot

Average Recommendation BUY Average Target Price 57.429
Number of Ratings 8 Current Quarters Estimate 0.414
FY Report Date 06 / 2026 Current Year's Estimate 1.751
Last Quarter’s Earnings 0.33 Median PE on CY Estimate N/A
Year Ago Earnings 1.62 Next Fiscal Year Estimate 2.088
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 8 8 8 8
Mean Estimate 0.41 0.48 1.75 2.09
High Estimates 0.47 0.51 1.84 2.58
Low Estimate 0.38 0.44 1.66 1.88
Coefficient of Variance 7.30 5.10 3.32 10.59

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 7 6
OVERWEIGHT 0 0 0
HOLD 1 1 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Overweight

Insider Actions for Omnicell Inc. - OMCL

Date Name Shares Transaction Value
Jan 13, 2026 Corey J. Manley EVP&CHIEF LEGAL/ADMIN OFFICER 91,674 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $49.9 per share 4,574,532.60
Dec 4, 2025 Randall A. Lipps CHAIRMAN, PRESIDENT AND CEO; Director 414,898 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $27.7 per share 11,492,674.60
Dec 4, 2025 Randall A. Lipps CHAIRMAN, PRESIDENT AND CEO; Director 386,648 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35.97 per share 13,907,728.56
Dec 4, 2025 Randall A. Lipps CHAIRMAN, PRESIDENT AND CEO; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 20, 2025 Randall A. Lipps CHAIRMAN, PRESIDENT AND CEO; Director 404,669 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $28.08 per share 11,363,105.52
May 20, 2025 Brian H. Nutt VP, Chief Accounting Officer 9,955 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $28.08 per share 279,536.40
May 20, 2025 Nchacha E. Etta EVP & CFO 128,497 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $28.08 per share 3,608,195.76

Omnicell Inc. in the News